Mari Dallas
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| T Cell Therapy of Opportunistic Cytomegalovirus Infection (NCT02982902) | Mari Dallas | 2020-05-27 |
| Antigen Specific Adoptive T Cell Therapy for Adenovirus Infection After Hematopoietic Stem Cell Transplantation (NCT03378102) | Mari Dallas | 2019-01-04 |
Track Mari Dallas automatically
Every clearance here is in the API, with alerts when new ones post.